Skip to main content

Table1 Demographics, WHO-Fc, NT-proBNP hemodynamics and cardiopulmonary exercise testing in IPAH, CTEPH and Control subjects

From: Variation of PetCO2 during incremental exercise and severity of IPAH and CTEPH

 

Control

IPAH

CTEPH

Age, years

34.75 ± 13.81

40.01 ± 15.20

59.33 ± 12.64#

Gender, male/female

26/18

50/114

60/75#

BMI, kg/m2

23.10 ± 2.67

22.69 ± 3.50

23.35 ± 3.13

WHO-Fc, I-II/III-IV

N

66/98

41/94

NT-proBNP, pg/ml

N

994.89 ± 1094.07

1261.95 ± 1353.18

Hemodynamics

mRAP, mmHg

N

5.89 ± 4.34

4.31 ± 4.11#

mPAP, mmHg

N

56.02 ± 13.35

45.93 ± 13.33#

PAWP, mmHg

N

7.21 ± 3.69

7.24 ± 3.91

CO, L/min

N

4.46 ± 1.57

4.67 ± 1.40#

CI, L/min/m2

N

2.63 ± 0.83

2.86 ± 0.69#

PVR, IU

N

12.96 ± 5.64

8.79 ± 4.17#

Cardiopulmonary exercise testing

PetCO2 at rest, mmHg

33.85 ± 4.07

26.78 ± 4.27

24.70 ± 3.97#

PetCO2 at unloaded, mmHg

37.33 ± 3.93

27.01 ± 5.36

24.42 ± 5.30#

PetCO2 at AT, mmHg

42.77 ± 5.06

26.94 ± 6.11

24.36 ± 5.81#

PetCO2 at peak, mmHg

39.58 ± 5.90

24.69 ± 6.49

22.49 ± 6.61#

peak VO2, ml/min

2148.17 (1496.67, 2527.58)

714.50 (567.50, 928.08)

727.33 (588.00, 853.00)

VO2/kg at peak, mL/min/kg

33.70 (29.35, 36.70)

12.30 (9.81, 15.45)

11.81 (10.32, 13.72)

  1. Data are presented as mean ± SD or median and interquartile #P < 0.05 versus IPAH patients using unpaired T test and Kruskal–Wallis test
  2. BMI body mass index, WHO-Fc World Health Organization functional class, NT-proBNP n-terminal natriuretic peptide type-B, mRAP mean right atrium pressure, mPAP mean pulmonary arterial pressure, PAWP pulmonary artery wedge pressure, CO Cardiac output, CI Cardiac index, PVR Pulmonary vascular resistance, Peak VO2 peak exercise oxygen uptake, AT anaerobic threshold, PetCO2 partial pressure of end-tidal carbon dioxide